Çelik Yalçın, Atıcı Aytuğ, Gülaşı Selvi, Makharoblıdze Khatuna, Eskandari Gülçin, Sungur Mehmet Ali, Akbayır Serin
Mersin University School of Medicine, Department of Neonatology Care Unit, 33343, Mersin, Turkey.
Mersin University Faculty of Medicine, Department of Neonatology, 33343, Mersin, Turkey.
Ital J Pediatr. 2015 Oct 15;41:79. doi: 10.1186/s13052-015-0188-5.
Therapeutic hypothermia (TH) has become standard care in newborns with moderate to severe hypoxic ischemic encephalopathy (HIE), and the 2 most commonly used methods are selective head cooling (SHC) and whole body cooling (WBC). This study aimed to determine if the effects of the 2 methods on some neural and inflammatory biomarkers differ.
This prospective randomized pilot study included newborns delivered after >36 weeks of gestation. SHC or WBC was administered randomly to newborns with moderate to severe HIE that were prescribed TH. The serum interleukin (IL)-1β, IL-6, neuron-specific enolase (NSE), brain-specific creatine kinase (CK-BB), tumor necrosis factor-alpha (TNF-α), and protein S100 levels, the urine S100B level, and the urine lactate/creatinine (L/C) ratio were evaluated 6 and 72 h after birth. The Bayley Scales of Infant and Toddler Development-III was administered at month 12 for assessment of neurodevelopmental findings.
The SHC group included 14 newborns, the WBC group included 10, the mild HIE group included 7, and the control group included 9. All the biomarker levels in the SHC and WBC groups at 6 and 72 h were similar, and all the changes in the biomarker levels between 6 and 72 h were similar in both groups. The serum IL-6 and protein S100 levels at 6 h in the SHC and WBC groups were significantly higher than in the control group. The urine L/C ratio at 6 h in the SHC and WBC groups was significantly higher than in the mild HIE and control groups. The IL-6 level and L/C ratio at 6 and 72 h in the patients that had died or had disability at month 12 were significantly higher than in the patients without disability at month 12.
The effects of SHC and WBC on the biomarkers evaluated did not differ. The urine L/C ratio might be useful for differentiating newborns with moderate and severe HIE from those with mild HIE. Furthermore, the serum IL-6 level and the L/C ratio might be useful for predicting disability and mortality in newborns with HIE.
治疗性低温(TH)已成为中重度缺氧缺血性脑病(HIE)新生儿的标准治疗方法,最常用的两种方法是选择性头部降温(SHC)和全身降温(WBC)。本研究旨在确定这两种方法对某些神经和炎症生物标志物的影响是否不同。
这项前瞻性随机试验研究纳入了孕周大于36周的新生儿。对确诊为TH的中重度HIE新生儿随机给予SHC或WBC治疗。在出生后6小时和72小时评估血清白细胞介素(IL)-1β、IL-6、神经元特异性烯醇化酶(NSE)、脑特异性肌酸激酶(CK-BB)、肿瘤坏死因子-α(TNF-α)和蛋白S100水平、尿S100B水平以及尿乳酸/肌酐(L/C)比值。在12月龄时采用贝利婴幼儿发展量表第三版评估神经发育结果。
SHC组包括14例新生儿,WBC组包括10例,轻度HIE组包括7例,对照组包括9例。SHC组和WBC组在6小时和72小时时所有生物标志物水平均相似,两组在6小时至72小时期间生物标志物水平的所有变化也相似。SHC组和WBC组在6小时时的血清IL-6和蛋白S100水平显著高于对照组。SHC组和WBC组在6小时时的尿L/C比值显著高于轻度HIE组和对照组。在12月龄时死亡或有残疾的患者在6小时和72小时时的IL-6水平和L/C比值显著高于12月龄时无残疾的患者。
SHC和WBC对所评估的生物标志物的影响没有差异。尿L/C比值可能有助于区分中重度HIE新生儿和轻度HIE新生儿。此外,血清IL-6水平和L/C比值可能有助于预测HIE新生儿的残疾和死亡情况。